Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Capital Expenditures (2024 - 2025)

Hinge Health (HNGE) has disclosed Capital Expenditures for 2 consecutive years, with -$300000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 116.2% to -$300000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $2.7 million for FY2024, 38.36% up from the prior year.
  • Capital Expenditures hit -$300000.0 in Q4 2025 for Hinge Health, up from -$2.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.9 million in Q4 2024 to a low of -$2.0 million in Q3 2025.